Cutaneous toxicity induced by antidepressants and second-generation antipsychotics in the united states food and drug administration adverse event reporting system.
Sign Up to like & getrecommendations! Published in 2024 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2024.2443962
Abstract: BACKGROUND Adverse cutaneous drug reactions have been reported with most drugs, including antidepressants (ADs) and second-generation antipsychotics (SGAs). The lack of extensive research on the relationship between ADs and SGAs, and cutaneous toxicity remains troubling.… read more here.
Keywords: second generation; drug; toxicity; cutaneous toxicity ... See more keywords
Cetuximab severe cutaneous toxicity… a gateway for bacteremia: case report.
Sign Up to like & getrecommendations! Published in 2022 at "Anti-cancer drugs"
DOI: 10.1097/cad.0000000000001312
Abstract: EGFR inhibitors used in the treatment of metastatic wild-RAS colorectal cancer in combination with chemotherapy are associated with dermatologic side events that are low grade in most cases. We report a case of severe cutaneous… read more here.
Keywords: cetuximab; cutaneous toxicity; toxicity; report ... See more keywords
Thiotepa-induced cutaneous toxicity in pediatric patients: Case report and implementation of preventive care guidelines
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218796905
Abstract: Thiotepa, a highly lipophilic, alkylating agent, and/or its active metabolites may be excreted in part via skin in patients receiving high-dose therapy. We present a case of cutaneous toxicity observed in a 4.5-year-old girl patient… read more here.
Keywords: cutaneous toxicity; care guidelines; preventive care; case ... See more keywords
Remodeling of dermal adipose tissue alleviates cutaneous toxicity induced by anti-EGFR therapy
Sign Up to like & getrecommendations! Published in 2022 at "eLife"
DOI: 10.7554/elife.72443
Abstract: Anti-epidermal growth factor receptor (EGFR) therapy–associated cutaneous toxicity is a syndrome characterized by papulopustular rash, local inflammation, folliculitis, and microbial infection, resulting in a decrease in quality of life and dose interruption. However, no effective… read more here.
Keywords: egfr therapy; adipose tissue; cutaneous toxicity;